Clinical Trial Update: Repurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose Rationale [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring repurposing empagliflozin and dapagliflozin for paediatric heart failure with a translational approach and dose rationale.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Empagliflozin (empagliflozin)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Heart Failure | Phase 2 | Status: UNKNOWN